首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1696274

日本醫療器材軟體市場 - 2025 至 2033 年

Japan Software as a Medical Device Market - 2025-2033

出版日期: 2025年03月25日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

日本軟體作為醫療器材市場在 2024 年達到 1,955 萬美元，預計到 2033 年將達到 9,620 萬美元，在 2025-2033 年預測期內的複合年成長率為 17.3%。

醫療設備軟體（SaMD）專為醫療目的而設計，支援疾病診斷、治療建議、患者監測和臨床決策。它使用人工智慧、機器學習和雲端運算等先進技術來改善醫療服務和患者治療結果。 SaMD 可在智慧型手機、平板電腦或基於雲端的系統等平台上獨立運行，因此具有高度的可存取性和可擴展性。

市場動態：

促進因素與約束因素

醫療保健領域雲端運算和物聯網 (IoT) 的整合日益加強

日本的軟體即醫療設備 (SaMD) 市場正透過雲端運算和物聯網的融合發生重大轉變。基於雲端的平台為醫療資料提供安全儲存、即時存取和進階分析，從而提高效率和決策能力。物聯網設備可實現持續的患者監測、遠端診斷和早期疾病檢測，從而減少醫院就診次數並改善患者的治療效果。雲端運算和物聯網之間的協同作用正在加速創新、擴大市場機會並提高醫療保健的可近性。

老年病患和醫護人員的數位素養有限

由於老年患者和醫療保健專業人員的數位素養有限，日本採用軟體即醫療設備 (SaMD) 解決方案面臨挑戰。老齡化人口難以適應數位健康應用，限制了遠端監控和人工智慧診斷的好處。傳統醫療保健提供者可能也難以將 SaMD 工具整合到他們的工作流程中。缺乏數位化能力可能導致對新技術的抵制、軟體使用不當以及對數位醫療解決方案的信任降低，從而減緩市場的成長。

市場領導者和先驅者
- 新興先鋒和傑出參與者
- 擁有最大銷售品牌的成熟領導者
- 擁有成熟產品的市場領導者
CXO 觀點
最新進展與突破
案例研究/正在進行的研究
監管和報銷情況
波特五力分析
供應鏈分析
SWOT 分析
未滿足的需求和差距
市場進入和擴張的推薦策略
情境分析：最佳情況、基本情況和最壞情況預測
定價分析和價格動態
關鍵意見領袖

第 5 章：按應用

疾病管理
診斷
治療監測
預測健康分析
其他

第 6 章：按指徵

糖尿病
心理健康
腫瘤學
心血管
呼吸系統疾病
其他

第7章：競爭格局與市場定位

競爭概況和主要市場參與者
市佔率分析與定位矩陣
策略夥伴關係、併購
產品組合和創新的關鍵發展
公司基準化分析

第8章：公司簡介

Japan Medical Device Corporation

公司概況
產品組合
- 產品描述
- 產品關鍵績效指標 (KPI)
- 歷史和預測產品銷售量
- 產品銷售量
財務概覽
- 公司收入
- 地區收入佔有率
- 收入預測
關鍵進展
- 合併與收購
- 關鍵產品開發活動
- 監管部門批准等
SWOT 分析

Nipro Corporation
Micron, Inc
Olympus Medical Systems
Anaut Inc

第9章：假設和研究方法

資料收集方法
數據三角測量
預測技術
數據驗證和確認

第 10 章：附錄

簡介目錄

Product Code: MD9375

The Japan software as a medical device market reached US$ 19.55 million in 2024 and is expected to reach US$ 96.20 million by 2033, growing at a CAGR of 17.3% during the forecast period 2025-2033.

Software as a Medical Device (SaMD) is designed for medical purposes, enabling disease diagnosis, treatment recommendations, patient monitoring, and clinical decision-making. It uses advanced technologies like AI, machine learning, and cloud computing to improve healthcare delivery and patient outcomes. SaMD operates independently on platforms like smartphones, tablets, or cloud-based systems, making it highly accessible and scalable.

Market Dynamics: Drivers & Restraints

Increasing Integration of Cloud Computing and the Internet of Things (IoT) in Healthcare

Japan's Software as a Medical Device (SaMD) market is being significantly transformed by the integration of cloud computing and IoT. Cloud-based platforms offer secure storage, real-time access, and advanced analytics for medical data, improving efficiency and decision-making. IoT devices enable continuous patient monitoring, remote diagnostics, and early disease detection, reducing hospital visits and improving patient outcomes. The synergy between cloud computing and IoT is accelerating innovation, expanding market opportunities, and improving healthcare accessibility.

Limited Digital Literacy Among Elderly Patients and Healthcare Professionals

The adoption of Software as a Medical Device (SaMD) solution in Japan faces challenges due to limited digital literacy among elderly patients and healthcare professionals. The aging population struggles with digital health applications, limiting the benefits of remote monitoring and AI-driven diagnostics. Traditional healthcare providers may also struggle to integrate SaMD tools into their workflows. This lack of digital proficiency can lead to resistance to new technologies, improper software utilization, and reduced trust in digital healthcare solutions, slowing the market's growth.

Segment Analysis

The Japan software as a medical device market is segmented based on application and indication.

Application:

The diagnostics from application segment is expected to dominate the software as a medical device market with the highest market share

Diagnostics is the process of identifying diseases, conditions, or medical abnormalities through various tests, assessments, and analyses. It includes imaging, laboratory testing, and clinical evaluations. Advancements in digital health now include AI-driven and software-based solutions, enhancing accuracy and efficiency. Effective diagnostics are crucial for preventive care, early intervention, and improving patient outcomes, guiding treatment decisions.

The diagnostics segment in this market is driven by the need for early disease detection, chronic conditions, AI-driven imaging, and data analytics. Remote diagnostics and telemedicine expansion improve healthcare accessibility. Regulatory approvals for AI-powered tools and cloud-based platforms support market growth.

The demand for cost-effective, accurate diagnostic solutions is driving SaMD adoption in precision medicine and personalized healthcare. Several companies are forming strategic partnerships to expand their diagnostic businesses. For instance, in January 2025, Monitor Corporation, a Korean medical AI company, partnered with Japanese digital healthcare provider Doctor-NET to sell its lung cancer diagnosis software in Japan. The AI-powered tool, MONCAD CTLN, aids radiologists in detecting lung cancer using chest CT scans. Doctor-NET has obtained manufacturing and sales certification for the software in Japan.

Competitive Landscape

The major Japan players in the software as a medical device market include Japan Medical Device Corporation, Nipro Corporation, Micron, Inc., Olympus Medical Systems and Anaut Inc. among others.

Key Developments

In May 2024, Anaut Inc., a surgical support software developer, received regulatory approval for its innovative medical device, "Eureka a," from the Ministry of Health, Labour and Welfare in Japan. The device, designed with advanced artificial intelligence, is set to revolutionize surgical practices.

Why Purchase the Report?

Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan software as a medical device market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Market Introduction and Scope

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. Executive Insights and Key Takeaways

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Application
2.4. Snippet by Indication

3. Dynamics

3.1. Impacting Factors
- 3.1.1. Drivers
  - 3.1.1.1. Increasing Integration of Cloud Computing and the Internet of Things (IoT) In Healthcare
  - 3.1.1.2. Advancements in Cloud Computing
- 3.1.2. Restraints
  - 3.1.2.1. Limited Digital Literacy Among Elderly Patients and Healthcare Professionals
  - 3.1.2.2. Supportive Regulatory Framework
- 3.1.3. Opportunity
  - 3.1.3.1. Increased Investment in HealthTech Startups
- 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with largest selling Brand
- 4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.6. Porter's Five Force Analysis
4.7. Supply Chain Analysis
4.8. SWOT Analysis
4.9. Unmet Needs and Gaps
4.10. Recommended Strategies for Market Entry and Expansion
4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.12. Pricing Analysis and Price Dynamics
4.13. Key Opinion Leaders

5. By Application

5.1. Introduction
- 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 5.1.2. Market Attractiveness Index, By Application
5.2. Disease Management*
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Diagnostics
5.4. Treatment Monitoring
5.5. Predictive Health Analytics
5.6. Others

6. By Indication

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 6.1.2. Market Attractiveness Index, By Indication
6.2. Diabetes*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Mental Health
6.4. Oncology
6.5. Cardiovascular
6.6. Respiratory Conditions
6.7. Others

7. Competitive Landscape and Market Positioning

7.1. Competitive Overview and Key Market Players
7.2. Market Share Analysis and Positioning Matrix
7.3. Strategic Partnerships, Mergers & Acquisitions
7.4. Key Developments in Product Portfolios and Innovations
7.5. Company Benchmarking

8. Company Profiles

8.1. Japan Medical Device Corporation*
- 8.1.1. Company Overview
- 8.1.2. Product Portfolio
  - 8.1.2.1. Product Description
  - 8.1.2.2. Product Key Performance Indicators (KPIs)
  - 8.1.2.3. Historic and Forecasted Product Sales
  - 8.1.2.4. Product Sales Volume
- 8.1.3. Financial Overview
  - 8.1.3.1. Company Revenue's
  - 8.1.3.2. Geographical Revenue Shares
  - 8.1.3.3. Revenue Forecasts
- 8.1.4. Key Developments
  - 8.1.4.1. Mergers & Acquisitions
  - 8.1.4.2. Key Product Development Activities
  - 8.1.4.3. Regulatory Approvals, etc.
- 8.1.5. SWOT Analysis
8.2. Nipro Corporation
8.3. Micron, Inc
8.4. Olympus Medical Systems
8.5. Anaut Inc